Michael Lisjak's most recent trade in Cyclo Therapeutics Inc - Ordinary Shares - Class A was a trade of 110,732 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 3, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cyclo Therapeutics Inc - O... | Michael Lisjak | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 110,732 | 110,732 | - | - | Stock Option (Right to Buy) | |
| Cyclo Therapeutics Inc - O... | Michael Lisjak | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 41,036 | 41,036 | - | - | Stock Option (Right to buy) | |
| Cyclo Therapeutics Inc - O... | Michael Lisjak | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 31,141 | 31,141 | - | - | Stock Options (Right to buy) | |
| Cyclo Therapeutics Inc - O... | Michael Lisjak | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2021 | 23,800 | 23,800 | - | - | Stock Option (Right to buy) | |
| Cyclo Therapeutics Inc - O... | Michael Lisjak | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2021 | 10,000 | 12,400 | - | 0 | Common Stock |